Metformin canonically facilitates improved insulin sensitivity and overall glucose uptake for type 2 diabetes (T2D) patients, but recent studies show the potential of repositioning metformin due to its anti-cancer properties [8,9,10,11,12]. This evidence concerns the gene INS and cancer.